F-1/A: KWESST Micro Systems Eyes $5 Million Capital Injection Through Share and Warrant Offering

KWESST Micro Systems Inc. is seeking to raise capital through an offering of common shares and pre-funded warrants, aiming to bolster working capital and fund product development.

Summary

• KWESST Micro Systems Inc. is offering common shares and pre-funded warrants in a firm commitment underwritten offering.
• The assumed public offering price is USD$0.428 per Common Share.
• Pre-funded warrants are offered to purchasers who would otherwise exceed ownership limits, exercisable at USD$0.001 per share.
• The offering includes Common Shares issuable upon exercise of the Pre-funded Warrants.
• The company has granted the underwriters a 45-day option to purchase additional Common Shares and/or Pre-funded Warrants.
• Net proceeds are estimated at USD$4.2 million, with half allocated to working capital and the other half to product development, primarily KWESST Lightning.
• Directors and executive officers have agreed to a 90-day lock-up period.
• The company is an 'emerging growth company' and a 'foreign private issuer', allowing for reduced reporting requirements.
• KWESST's financial statements are prepared in accordance with IFRS and in Canadian dollars.
• The company has identified material weaknesses in its internal controls over financial reporting.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the capital raise is a positive step, the identified risks, potential dilution, and existing financial weaknesses temper the overall outlook.

Positives

• The offering will provide additional capital for working capital and product development.
• The company has a 45-day option to the representatives of the underwriters to purchase additional shares.
• The company is an emerging growth company and a foreign private issuer, which affects its reporting obligations.

Negatives

• Investors will experience immediate and substantial dilution as a result of this offering.
• Management will have broad discretion as to the use of the proceeds from this offering, and we may not use the proceeds effectively.
• The company has identified material weaknesses in its internal controls over financial reporting, which it is working to remediate.
• The market price of our Common Shares may be adversely impacted by the release of certain of our securities that are currently escrowed if the holders immediately trade these securities upon release.
• We may not meet the continued listing requirements of Nasdaq, which could cause our Common Shares to be delisted.

Risks

• Immediate and substantial dilution for new investors.
• Management's discretion in using proceeds may not be effective.
• Potential delisting from Nasdaq if minimum bid price requirements are not met.
• Reliance on third-party suppliers may create risks related to our potential inability to obtain an adequate supply of components or materials and reduced control over pricing and timing of delivery of components and materials.
• Potential cancellation or loss of customer contracts if we are unable to meet contract performance requirements.
• We will be reliant on information technology systems and may be subject to damaging cyber-attacks.
• Protecting and defending against intellectual property claims may have a material adverse effect on our business.
• Our business is subject to certain risks inherent in international business, including regional conflicts that may impact our operations and may be beyond our control.
• Our directors, officers or members of management may have conflicts of interest and it may not be possible for foreign investors to enforce actions against us, and our directors and officers.
• Our insurance policies may be inadequate to fully protect us from material judgments and expenses.
• Our Common Shares may experience extreme stock price volatility unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Common Shares.
• We are subject to extensive government regulation in the United States for our products and may not be able to comply with changes in government policies and legislation.
• Rapidly changing technology and evolving industry standards could result in product obsolescence or short product life cycles.
• If we are unable to satisfy the requirements of Sarbanes-Oxley Act of 2002, as amended ('Sarbanes-Oxley') or our internal controls over financial reporting are not effective, the reliability of our financial statements may be questioned.
• We may lose foreign private issuer status in the future, which could result in additional costs and expenses.

Future Outlook

The company expects to use the net proceeds from this Offering for working capital and other general corporate purposes and for product development and business development relating to BLDS, KWESST Lightning, ARWEN and PARA OPSTM. The majority of net proceeds to be used for product development and business development are expected to be used for the development of KWESST Lightning.

Industry Context

The company operates in the military, security forces, and public safety markets, focusing on next-generation tactical systems. The document mentions Fact.MR data indicating the global non-lethal weapons market was approximately USD$4.95 billion in 2023 and is projected to reach USD$7.6 billion in 2028 (a 4.3% compound annual growth rate).

Comparison to Industry Standards

• The company competes with Byrna Technologies Inc., United Tactical Systems, LLC, Axon Enterprises, Inc., and Wrap Technologies Inc. in the non-lethal market.
• In the ARWEN product line, the company competes with DEFTEC / Safariland's 40 mm LTM launchers and ALS (a Pacem Defense Company)'s single shot 37mm and 40mm launchers and 40mm multi-shot launchers.
• For digitization and counter threat business lines, the company competes with R&D labs funded by the U.S. Department of Defense, Fabrique Nationale Herstal S.A., Motorola (Tactical TV Decoys), Synchopated Engineering (Mockingbird RF Signal Emulator), and CACI Systemware (MAGPIE).

Stakeholder Impact

• Shareholders will experience dilution.
• Employees may benefit from increased investment in product development.
• Customers may see improved products and services due to increased R&D.

Next Steps

• The underwriters expect to deliver the securities to the investors on or about , 2024.
• The majority of net proceeds to be used for product development and business development are expected to be used for the development of KWESST Lightning.

Key Dates

Keywords

common shares, pre-funded warrants, offering, KWESST, capital raise, product development, working capital, securities, Nasdaq, TSXV